These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Lipoprotein(a). Its importance as an additional atherosclerosis marker]. Campos E. Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184 [Abstract] [Full Text] [Related]
3. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. Scanu AM. Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266 [Abstract] [Full Text] [Related]
4. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance]. Armstrong VW. Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832 [Abstract] [Full Text] [Related]
7. [Lipoprotein (a)--link between lipid metabolism and coagulation system?]. Riesen WF. Schweiz Med Wochenschr; 1991 Dec 07; 121(49):1813-8. PubMed ID: 1836645 [Abstract] [Full Text] [Related]
8. [Lipoprotein(a): a link between thrombosis and atherosclerosis?]. Hansen PR. Ugeskr Laeger; 1993 May 17; 155(20):1527-30. PubMed ID: 8316983 [Abstract] [Full Text] [Related]
9. Physiological and clinical importance of lipoprotein(a). Romics L, Karádi I, Császár A, Kostner GM. Tokai J Exp Clin Med; 1990 May 17; 15(2-3):149-54. PubMed ID: 2151833 [Abstract] [Full Text] [Related]
11. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)]. Krempler F. Acta Med Austriaca; 1980 May 17; 7(4-5):101-3. PubMed ID: 6454320 [Abstract] [Full Text] [Related]
12. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Boffa MB, Marcovina SM, Koschinsky ML. Clin Biochem; 2004 May 17; 37(5):333-43. PubMed ID: 15087247 [Abstract] [Full Text] [Related]
13. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1). Dieplinger H, Kronenberg F. Wien Klin Wochenschr; 1999 Jan 15; 111(1):5-20. PubMed ID: 10067265 [Abstract] [Full Text] [Related]
14. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis]. Kullich W, Machreich K. Wien Med Wochenschr; 1994 Jan 15; 144(17):407-11. PubMed ID: 7839688 [Abstract] [Full Text] [Related]
15. A potential basis for the thrombotic risks associated with lipoprotein(a). Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. Nature; 1989 May 25; 339(6222):301-3. PubMed ID: 2542796 [Abstract] [Full Text] [Related]
16. [Genetic predisposition for the multiple metabolic syndrome. Part 4. Apolipoprotein E and lipoprotein (a)]. Sobra J, Ceska R. Cas Lek Cesk; 1999 Mar 29; 138(7):203-8. PubMed ID: 10510535 [Abstract] [Full Text] [Related]
17. Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. Scanu AM. J Lab Clin Med; 1990 Aug 29; 116(2):142-6. PubMed ID: 2144311 [Abstract] [Full Text] [Related]
18. Lipoprotein(a) as a marker for coronary heart disease. Duriez P, Dallongeville J, Fruchart JC. Br J Clin Pract Suppl; 1996 Jan 29; 77A():54-61. PubMed ID: 8729591 [Abstract] [Full Text] [Related]
19. Lipoprotein(a) as a marker for coronary heart disease. Duriez P, Dallongeville J, Fruchart JC. Br J Clin Pract Suppl; 1994 Dec 29; (77):51-8. PubMed ID: 19496273 [Abstract] [Full Text] [Related]
20. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?]. de Brouckère V, Liénart F, Ducobu J. Rev Med Brux; 2010 Dec 29; 31(3):171-6. PubMed ID: 20687444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]